Dr. Josep Bassaganya-Riera President, Founding Director & Distinguished Professor

Dr. Josep Bassaganya-Riera is the President and Founding Director of the NIMML Institute, a 501 (c)(3) public charity foundation. He is an innovator, thought leader, and serial entrepreneur, with more than 20 years of R&D experience in the interface of immunology and advanced computational modeling. As a Distinguished Professor, he has published over 200 peer-reviewed articles, book chapters and books on the acceleration of biopharmaceutical development, bioinformatics, and computational immunology, and he has contributed 50 patents in immunology and autoimmune disease treatment. He has founded 3 award-winning Companies (Landos Biopharma, Pervida and Biotherapeutics), raising over $200 million in non-dilutive and equity financing rounds. He served as the Director of the NIH-funded Center for Modeling Immunity to Enteric Pathogens under the modeling immunity for biodefense (MIB) program. Through its corporate culture, encapsulated in 4 pillars: be bold and decisive, never give up, be solution-oriented and do the impossible, these values empower NIMML Institute members to think outside the box to achieve creative and innovative solutions that promote technological innovation.

Selected Publications

In The News

Interviews

Talks

Our Mission

To comprehensively and systematically characterize mechanisms of action underlying infectious, metabolic and autoimmune diseases; The NIMML Institute will translate this new scientific knowledge to identify new therapeutic targets and develop innovative therapeutics for human diseases that are safer and more effective.

Our Vision

To become a world-leading transdisciplinary research institute that combines advanced computational methods with preclinical, translational and clinical research and development.

Our Values

Be bold and decisive in solving the world’s most pressing challenges.

Never give up in finding disease treatments.

Be solution-oriented in the face of problems.

Do the Impossible to address the unmet needs of patients.

Open positions

What NIMML Students Say

"The work going on at NIMML is innovative, cutting-edge, and really driven by the new paths that both research and medicine are continuing to take. I know that what I have learned here will help me both directly and indirectly in the future. "

- Kathryn Hopkins

Please email us at [email protected] if you would like to discuss the possibility of contributing financial support for our research, or if you are ready to contribute a tax-deductible donation.